Genomic medicine
Features
Silencing the genes that harm the brain
Personalising antidepressants: should we be genetic testing?
Cancer pharmacogenomics testing: are we hitting the mark?
Are pharmacists ready for the genomic revolution?
Pharmacogenomic testing: coming to a community pharmacy near you
Gene therapy: from catastrophe to cure in 20 years
Latest news
-
Pharmacogenomic testing in community pharmacies to be considered as part of UK-wide review
-
Whole-genome sequencing is ‘feasible’ for screening in primary care, research suggests
-
First routine clopidogrel genotype testing introduced at health board
-
First pharmacogenomic testing service to be launched by pharmacy multiple later in 2022
-
Pharmacogenomics should be embedded into lifelong education and training, says RPS
-
No pharmacists apply for fully funded place on genomic medicine course
-
Only one in ten pharmacy professionals feel confident on pharmacogenomics
-
Pharmacogenomic testing may be effective in depression treatment, according to study
Opinion
Pharmacogenomics is the future of prescribing in psychiatry
How we set up the UK’s first clopidogrel genomics testing system
We must start using pharmacogenomic information to optimise medicines for older people
Using genetic testing to prevent DPD toxicity
We cannot ignore race when it comes to pharmacogenomics
PJ view: Time for a conversation in pharmacy about genomic medicine
Targeted medicines: how pharmacists can lead a pharmacogenomics revolution
Learning
Medication restrictions for patients receiving CAR-T therapy
Familial hypercholesterolaemia: identification and management
DPYD genetic testing and the future of pharmacogenomic testing in routine care
How community pharmacy pharmacogenomics testing services around the world can inform their design and delivery in the UK
